Methyl iodide → Methyl 1-(5-(3-fluorophenyl)-2-methylthiazole-4-carbonyl)-5-methoxypiperidine-2-carboxylate
Reaction equation
[CH3:1]I.[F:3][C:4]1[CH:5]=[C:6]([C:10]2[S:14][C:13]([CH3:15])=[N:12][C:11]=2[C:16]([N:18]2[CH2:23][CH:22]([OH:24])[CH2:21][CH2:20][CH:19]2[C:25]([O:27][CH3:28])=[O:26])=[O:17])[CH:7]=[CH:8][CH:9]=1>CC#N.C(Cl)Cl>[F:3][C:4]1[CH:5]=[C:6]([C:10]2[S:14][C:13]([CH3:15])=[N:12][C:11]=2[C:16]([N:18]2[CH2:23][CH:22]([O:24][CH3:1])[CH2:21][CH2:20][CH:19]2[C:25]([O:27][CH3:28])=[O:26])=[O:17])[CH:7]=[CH:8][CH:9]=1Participants
5
Procedure
MeI (6.8 mmol, 0.43 mL) was added to a mixture of methyl 1-(5-(3-fluorophenyl)-2-methylthiazole-4-carbonyl)-5-hydroxypiperidine-2-carboxylate (0.68 mmol, 0.26 g) and Ag2O (3.4 mmol, 0.8 g) in CH3CN (3 mL) at rt. The resulting mixture was stirred at rt for two days. The reaction mixture was diluted with DCM and filtered through a pad of diatomaceous earth. The filtrate was concentrated in vacuo to give desired product methyl 1-(5-(3-fluorophenyl)-2-methylthiazole-4-carbonyl)-5-methoxypiperidine-2-carboxylate which was used for next step without further purification (Y: 96%).
Workup
- filtrationfiltered through a pad of diatomaceous earth
- concentrationThe filtrate was concentrated in vacuo
Sources & evidence
- ORD record
- ord-6c22ea93e8a9402bb82b99d307ff2baa
- Source dataset
- uspto-grants-2016_09
- Patent number
- US09440982B2
Reaction notes
Loading…